SOLIGENIX, INC. Fair Value Adjustment of Warrants
SOLIGENIX, INC. (SNGX) reported Fair Value Adjustment of Warrants of -$1.54 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2018-03-15
- SOLIGENIX, INC. fair value adjustment of warrants for the quarter ending 2016-12-31 was -$432.05K, a 246.70% decline year-over-year.
- SOLIGENIX, INC. fair value adjustment of warrants for the quarter ending 2016-09-30 was $176.29K.
- SOLIGENIX, INC. fair value adjustment of warrants for the quarter ending 2016-06-30 was -$525.33K, a 127.03% decline year-over-year.
- SOLIGENIX, INC. fair value adjustment of warrants for the quarter ending 2016-03-31 was -$760.16K, a 125.24% decline year-over-year.
- SOLIGENIX, INC. fair value adjustment of warrants for fiscal 2016 was -$1.54M, a 228.24% decline from fiscal 2015.
- SOLIGENIX, INC. fair value adjustment of warrants for fiscal 2015 was $1.20M.
- SOLIGENIX, INC. fair value adjustment of warrants for fiscal 2014 was -$3.44M, a 194.02% decline from fiscal 2013.
- SOLIGENIX, INC. fair value adjustment of warrants for fiscal 2013 was $3.65M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2016-12-31 | -$432.05K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$255.76K derived: sum of 2 quarters · filed 2018-03-15 | -$781.08K derived: sum of 3 quarters · filed 2018-03-15 | -$1.54M 10-K · filed 2018-03-15 |
| 2016-09-30 | $176.29K 10-Q · filed 2017-11-06 | -$349.04K derived: sum of 2 quarters · filed 2017-11-06 | -$1.11M 10-Q · filed 2017-11-06 | -$814.69K derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | -$525.33K 10-Q · filed 2017-08-11 | -$1.29M 10-Q · filed 2017-08-11 | -$990.98K derived: sum of 3 quarters · filed 2017-08-11 | -$5.04M derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | -$760.16K 10-Q · filed 2017-05-11 | -$465.65K derived: sum of 2 quarters · filed 2017-05-11 | -$4.51M derived: sum of 3 quarters · filed 2017-05-11 | -$2.57M derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | $294.50K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | -$3.75M derived: sum of 2 quarters · filed 2017-03-27 | -$1.81M derived: sum of 3 quarters · filed 2017-03-27 | $1.20M 10-K · filed 2017-03-27 |
| 2015-09-30 | -$4.05M 10-Q · filed 2016-11-10 | -$2.10M derived: sum of 2 quarters · filed 2016-11-10 | $907.37K 10-Q · filed 2016-11-10 | -$2.73M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $1.94M 10-Q · filed 2016-08-11 | $4.96M 10-Q · filed 2016-08-11 | $1.32M derived: sum of 3 quarters · filed 2016-08-11 | $523.82K derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | $3.01M 10-Q · filed 2016-05-12 | -$628.28K derived: sum of 2 quarters · filed 2016-05-12 | -$1.42M derived: sum of 3 quarters · filed 2016-05-12 | -$2.17M derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | -$3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-24 | -$4.43M derived: sum of 2 quarters · filed 2016-03-24 | -$5.18M derived: sum of 3 quarters · filed 2016-03-24 | -$3.44M 10-K · filed 2016-03-24 |
| 2014-09-30 | -$791.39K 10-Q · filed 2015-11-12 | -$1.54M derived: sum of 2 quarters · filed 2015-11-12 | $203.70K 10-Q · filed 2015-11-12 | -$1.49M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | -$746.99K 10-Q · filed 2015-08-12 | $995.10K 10-Q · filed 2015-08-12 | -$699.55K derived: sum of 3 quarters · filed 2015-08-12 | $4.00M derived: sum of 4 quarters · filed 2015-08-12 |
| 2014-03-31 | $1.74M 10-Q · filed 2015-05-14 | $47.44K derived: sum of 2 quarters · filed 2015-05-14 | $4.75M derived: sum of 3 quarters · filed 2015-05-14 | |
| 2013-12-31 | -$1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | $3.01M derived: sum of 2 quarters · filed 2015-03-25 | $3.65M 10-K · filed 2015-03-25 | |
| 2013-09-30 | $4.70M 10-Q · filed 2014-11-10 | $5.35M 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |